Effects of a comprehensive rehabilitation programme in patients with three-vessel coronary disease

C Monpere1, G Francois, M Brochier

  • 1Centre de Réadaptation Cardiovasculaire Bois Gibert, Ballan Mire, France.

European Heart Journal
|November 1, 1988
PubMed

Insights

Cardiac rehabilitation is safe and effective for patients with three-vessel coronary disease, improving functional capacity and return to work. This program enhances patient confidence and outcomes after myocardial infarction or unstable angina.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine

Background:

  • Three-vessel coronary disease poses significant risks, especially when revascularization is not an option.
  • Patients often experience reduced functional capacity post-myocardial infarction or unstable angina.

Purpose of the Study:

  • To evaluate the safety and efficacy of a cardiac rehabilitation program for patients with three-vessel coronary disease.
  • To assess improvements in functional capacity and long-term outcomes.

Main Methods:

  • A 4-week rehabilitation program was implemented for 46 patients (31 post-myocardial infarction, 15 post-unstable angina).
  • Stress tests were used to measure maximal work-load and ischemic threshold before and after rehabilitation.
  • Long-term follow-up assessed cardiac events, symptoms, and return to work.

Main Results:

  • Significant improvements were observed in maximal work-load (103.6 to 126.4 W, P<0.001) and ischemic threshold (82 to 91 W, P<0.05).
  • During 20.8 months follow-up, 8.7% mortality occurred, primarily in patients with low ejection fraction (EF < 0.45).
  • 85% of patients returned to work within 1.7 months post-rehabilitation.

Conclusions:

  • Cardiac rehabilitation is a safe and beneficial intervention for selected three-vessel coronary disease patients.
  • The program leads to enhanced physical function, improved quality of life, and a high rate of return to work.
  • Close medical supervision is crucial for managing patients with reduced left ventricular ejection fraction.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
632
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659